Impact of Plasma Lp-PLA2 Activity on the Progression of Aortic Stenosis
- 1 January 2015
- journal article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 8 (1) , 26-33
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP-114997, MOP-2455048)
- Foundation of the Quebec Heart and Lung Institute
- Eli Lilly Canada
This publication has 45 references indexed in Scilit:
- Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve DiseaseJACC, 2014
- Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosisClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Calcific Aortic Valve Disease: Not Simply a Degenerative ProcessCirculation, 2011
- Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosisInternational Journal of Cardiology, 2010
- Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart StudyPLOS Genetics, 2010
- Usefulness of the Valvuloarterial Impedance to Predict Adverse Outcome in Asymptomatic Aortic StenosisJACC, 2009
- Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic StenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosisHeart, 2007
- Lipoprotein-associated phospholipase A2 as a target of therapyCurrent Opinion in Lipidology, 2005
- Predictors of Outcome in Severe, Asymptomatic Aortic StenosisNew England Journal of Medicine, 2000